Deng Xizhi

Huang Jingqiu, Chang Zhaohui, Liu Lian, Lai Cheng, Deng Xizhi, Jiang Bin et al.

Maraviroc, a CCR5 inhibitor, prevented retinal ganglion cell death and preserved optic nerve function in an injury model by modulating the CCL5/CCR5/CTSS pathway. This suggests a promising neuroprotective strategy for glaucoma.

Zhang Nan, Zhang Pengyu, Deng Xizhi, Zhu Min, Hu Yixin, Ji Dongxiao et al.

Nicotinamide riboside (NR) was found to mitigate glucocorticoid-induced glaucoma by reducing extracellular matrix deposition and mitochondrial damage in the trabecular meshwork, suggesting NR is a promising therapeutic for GIG.